Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E20.54 EPS (ttm)1.67 Insider Own0.05% Shs Outstand5.56B Perf Week1.12%
Market Cap192.02B Forward P/E11.16 EPS next Y3.06 Insider Trans-6.39% Shs Float5.55B Perf Month-2.26%
Income9.36B PEG3.05 EPS next Q0.79 Inst Own67.60% Short Float1.14% Perf Quarter-13.22%
Sales47.64B P/S4.03 EPS this Y-33.10% Inst Trans- Short Ratio1.58 Perf Half Y-2.15%
Book/sh11.71 P/B2.92 EPS next Y-7.21% ROA5.70% Target Price41.09 Perf Year-0.86%
Cash/sh2.18 P/C15.71 EPS next 5Y6.73% ROE14.90% 52W Range26.42 - 43.08 Perf YTD-7.09%
Dividend1.56 P/FCF51.74 EPS past 5Y2.20% ROI7.60% 52W High-20.61% Beta0.67
Dividend %4.56% Quick Ratio1.00 Sales past 5Y-3.00% Gross Margin79.10% 52W Low29.44% ATR0.61
Employees78500 Current Ratio1.40 Sales Q/Q11.80% Oper. Margin15.70% RSI (14)42.39 Volatility2.15% 1.42%
OptionableYes Debt/Eq0.63 EPS Q/Q125.10% Profit Margin20.20% Rel Volume1.13 Prev Close34.39
ShortableYes LT Debt/Eq0.59 EarningsFeb 02 BMO Payout87.90% Avg Volume39.92M Price34.20
Recom2.60 SMA20-0.54% SMA50-4.56% SMA200-3.36% Volume45,191,481 Change-0.55%
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Mar-05-21 01:52AM  
Mar-04-21 07:01PM  
05:45PM  
03:57PM  
02:44PM  
02:32PM  
02:06PM  
11:30AM  
11:09AM  
11:01AM  
10:17AM  
10:10AM  
10:00AM  
08:41AM  
08:22AM  
08:12AM  
07:27AM  
06:23AM  
06:12AM  
01:00AM  
Mar-03-21 07:03PM  
03:16PM  
03:02PM  
02:35PM  
02:18PM  
12:25PM  
12:05PM  
11:49AM  
10:47AM  
08:53AM  
08:46AM  
07:44AM  
07:13AM  
06:14AM  
05:47AM  
03:02AM  
02:33AM  
Mar-02-21 06:00PM  
03:51PM  
01:24PM  
12:12PM  
12:08PM  
11:51AM  
11:46AM  
10:58AM  
10:36AM  
10:32AM  
08:44AM  
08:18AM  
08:11AM  
07:59AM  
07:18AM  
07:00AM  
07:00AM  
06:58AM  
06:49AM  
06:05AM  
06:02AM  
04:35AM  
02:56AM  
Mar-01-21 11:15PM  
07:17PM  
05:14PM  
04:18PM  
04:16PM  
02:59PM  
01:56PM  
12:48PM  
12:45PM  
12:39PM  
11:07AM  
10:32AM  
10:27AM  
08:54AM  
08:38AM  
08:21AM  
07:56AM  
07:43AM  
07:15AM  
06:01AM  
06:00AM  
01:13AM  
Feb-28-21 04:57PM  
01:55PM  
09:37AM  
09:22AM  
06:01AM  
Feb-27-21 08:22PM  
06:39PM  
06:25PM  
06:19PM  
04:19PM  
02:34PM  
02:11PM  
08:17AM  
Feb-26-21 08:56PM  
07:24PM  
05:54PM  
05:44PM  
05:38PM  
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc, Verily Life Sciences LLC, Merck KGaA, Valneva SE, IDEAYA Biosciences, Inc., BioNTech SE, Jiangsu Alphamab Biopharmaceuticals Co., Ltd, BioInvent International AB, Sosei Group Corporation, LianBio, and Imcyse S.A. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5513,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM
KMX CarMax, Inc. daily Stock Chart
KMX [NYSE]
CarMax, Inc.
IndexS&P 500 P/E26.52 EPS (ttm)4.54 Insider Own0.10% Shs Outstand163.73M Perf Week1.16%
Market Cap19.46B Forward P/E21.07 EPS next Y5.71 Insider Trans-71.87% Shs Float162.04M Perf Month-2.23%
Income751.90M PEG4.18 EPS next Q1.28 Inst Own99.80% Short Float3.55% Perf Quarter25.13%
Sales18.75B P/S1.04 EPS this Y11.20% Inst Trans-0.82% Short Ratio3.73 Perf Half Y10.79%
Book/sh25.21 P/B4.77 EPS next Y27.09% ROA3.60% Target Price124.62 Perf Year32.64%
Cash/sh1.46 P/C82.24 EPS next 5Y6.34% ROE19.50% 52W Range37.59 - 128.58 Perf YTD27.36%
Dividend- P/FCF35.83 EPS past 5Y14.30% ROI4.60% 52W High-6.44% Beta1.66
Dividend %- Quick Ratio0.70 Sales past 5Y7.30% Gross Margin12.90% 52W Low220.03% ATR3.64
Employees27050 Current Ratio2.60 Sales Q/Q8.20% Oper. Margin5.20% RSI (14)51.81 Volatility2.81% 2.48%
OptionableYes Debt/Eq3.64 EPS Q/Q36.50% Profit Margin4.00% Rel Volume0.54 Prev Close121.80
ShortableYes LT Debt/Eq3.53 EarningsDec 22 BMO Payout0.00% Avg Volume1.54M Price120.30
Recom1.60 SMA20-1.97% SMA506.50% SMA20020.43% Volume828,253 Change-1.23%
Jan-19-21Upgrade Northcoast Neutral → Buy $130
Dec-09-20Downgrade JP Morgan Overweight → Neutral $115
Oct-19-20Initiated Seaport Global Securities Buy $113
Oct-05-20Initiated Exane BNP Paribas Underperform
Jun-01-20Initiated JP Morgan Overweight $105
May-12-20Upgrade Wedbush Neutral → Outperform $70 → $90
Feb-07-20Initiated Evercore ISI Outperform
Feb-06-20Initiated Evercore ISI Outperform
Jun-28-19Initiated Argus Buy $100
Jun-28-19Downgrade Northcoast Buy → Neutral
Jun-24-19Downgrade Buckingham Research Buy → Neutral $94
Apr-01-19Upgrade Stephens Equal-Weight → Overweight $83 → $93
Jan-07-19Upgrade Buckingham Research Neutral → Buy
Dec-24-18Upgrade Guggenheim Neutral → Buy
Oct-02-18Initiated Wolfe Research Peer Perform
Sep-27-18Upgrade Robert W. Baird Neutral → Outperform
Jul-10-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-25-18Downgrade Guggenheim Buy → Neutral
Jun-25-18Downgrade Buckingham Research Buy → Neutral
Jun-06-18Initiated Gabelli & Co Buy $95
Mar-03-21 09:25AM  
09:00AM  
Mar-02-21 12:10PM  
Feb-27-21 02:19PM  
Feb-26-21 07:00AM  
Feb-16-21 07:13AM  
Feb-02-21 06:50AM  
Feb-01-21 01:45AM  
Jan-26-21 11:36AM  
Jan-22-21 11:01AM  
Jan-21-21 11:30AM  
Jan-19-21 04:18PM  
Jan-18-21 08:28AM  
Jan-13-21 07:49AM  
Jan-12-21 07:30AM  
Dec-31-20 07:12AM  
Dec-28-20 06:10PM  
04:24PM  
10:46AM  
Dec-24-20 07:12AM  
Dec-23-20 09:39AM  
08:39AM  
Dec-22-20 07:01PM  
10:35AM  
08:16AM  
08:05AM  
07:15AM  
07:13AM  
07:02AM  
06:50AM  
03:27AM  
Dec-21-20 10:06AM  
08:53AM  
08:49AM  
07:47AM  
07:10AM  
Dec-20-20 03:08PM  
09:22AM  
Dec-17-20 11:00AM  
Dec-15-20 12:30PM  
Dec-08-20 04:30PM  
Dec-07-20 11:28AM  
Nov-30-20 08:45AM  
Nov-22-20 03:18AM  
Nov-20-20 04:49PM  
Nov-16-20 05:25PM  
Oct-27-20 12:06PM  
10:26AM  
Oct-26-20 10:46PM  
12:04PM  
Oct-23-20 09:39AM  
Oct-14-20 03:52PM  
Oct-09-20 08:42PM  
Oct-04-20 09:32AM  
Oct-03-20 04:52PM  
Oct-02-20 11:32AM  
09:51AM  
06:16AM  
Oct-01-20 01:53PM  
Sep-30-20 08:52AM  
Sep-29-20 12:41PM  
11:33AM  
06:57AM  
Sep-28-20 09:57AM  
09:03AM  
06:18AM  
Sep-25-20 01:41PM  
Sep-24-20 08:00PM  
06:07PM  
04:14PM  
01:18PM  
12:54PM  
12:03PM  
11:07AM  
10:32AM  
10:28AM  
10:05AM  
09:45AM  
09:23AM  
07:05AM  
07:00AM  
06:50AM  
Sep-23-20 10:55AM  
10:07AM  
09:50AM  
Sep-22-20 12:28PM  
Sep-21-20 02:18PM  
Sep-20-20 07:22PM  
03:00PM  
Sep-17-20 12:30PM  
Sep-15-20 01:09PM  
Sep-14-20 08:00PM  
Sep-11-20 07:27AM  
Sep-10-20 04:30PM  
Sep-09-20 08:00PM  
08:00PM  
09:28AM  
Sep-08-20 10:40AM  
Sep-03-20 01:43PM  
Aug-24-20 01:16PM  
CarMax, Inc., through its subsidiaries, operates as a retailer of used vehicles in the United States. The company operates in two segments, CarMax Sales Operations and CarMax Auto Finance. It offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles; vehicles that do not meet its retail standards to licensed dealers through on-site wholesale auctions; and extended protection plans to customers at the time of sale. The company also provides reconditioning and vehicle repair services; and financing alternatives for retail customers across a range of credit spectrum through its CarMax Auto Finance and arrangements with various financial institutions. As of February 29, 2020, it operated approximately 216 stores and 2 new car franchises. CarMax, Inc. was founded in 1993 and is based in Richmond, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Daniels Jon GSVP, CAFFeb 08Option Exercise51.6320,1291,039,26021,609Feb 10 05:15 PM
Daniels Jon GSVP, CAFFeb 08Sale127.5420,1292,567,3411,480Feb 10 05:15 PM
Mayor-Mora Enrique NSVP & CFOFeb 05Option Exercise58.3810,902636,45917,416Feb 08 04:50 PM
Mayor-Mora Enrique NSVP & CFOFeb 05Sale126.319,1471,155,3588,269Feb 08 04:50 PM
Hill Edwin JEVP & COOJan 21Option Exercise58.3835,0002,043,30043,258Jan 22 04:41 PM
Hill Edwin JEVP & COOJan 21Sale120.7035,0004,224,5838,258Jan 22 04:41 PM
Mayor-Mora Enrique NSVP & CFOJan 20Option Exercise58.389,000525,42014,386Jan 22 04:41 PM
Newberry Darren CSVPJan 20Option Exercise60.0420,1751,211,22125,756Jan 22 04:42 PM
Nash William DPresident & CEOJan 20Option Exercise53.62100,0005,362,000217,000Jan 22 04:42 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJan 20Option Exercise58.3820,0001,167,60042,440Jan 22 04:41 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJan 20Sale123.8220,0002,476,40022,440Jan 22 04:41 PM
Newberry Darren CSVPJan 20Sale124.0120,1752,501,9485,581Jan 22 04:42 PM
Nash William DPresident & CEOJan 20Sale123.14100,00012,313,652117,000Jan 22 04:42 PM
Mayor-Mora Enrique NSVP & CFOJan 20Sale117.087,872921,6546,514Jan 22 04:41 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJan 14Option Exercise58.3815,000875,70037,440Jan 15 04:38 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJan 14Sale106.6815,0001,600,20022,440Jan 15 04:38 PM
Nash William DPresident & CEOJan 12Option Exercise51.6358,6743,029,339175,674Jan 14 05:14 PM
Hill Edwin JEVP & COOJan 12Option Exercise51.6347,0962,431,56655,354Jan 14 05:14 PM
Cafritz Diane LSVP & CHROJan 12Option Exercise62.0117,8611,107,56922,507Jan 14 05:14 PM
Reedy Thomas W JREVP of FinanceJan 12Option Exercise73.7635,3212,605,27755,300Jan 14 05:15 PM
Reedy Thomas W JREVP of FinanceJan 12Sale106.0435,3213,745,43919,979Jan 14 05:15 PM
Cafritz Diane LSVP & CHROJan 12Sale106.3217,8611,898,9824,646Jan 14 05:14 PM
Hill Edwin JEVP & COOJan 12Sale106.1147,0964,997,3578,258Jan 14 05:14 PM
Nash William DPresident & CEOJan 12Sale106.2358,6746,232,939117,000Jan 14 05:14 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJan 08Option Exercise58.3815,000875,70039,440Jan 11 04:34 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJan 08Sale102.5115,0001,537,65024,440Jan 11 04:34 PM
Reedy Thomas W JREVP of FinanceDec 30Sale93.5314,6471,369,93419,979Dec 30 05:43 PM
ONeil Mark FDirectorSep 30Buy93.402,700252,1805,709Oct 02 04:15 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryAug 10Option Exercise53.608,863475,03733,303Aug 11 05:33 PM
Reedy Thomas W JREVP of FinanceAug 10Option Exercise68.1474,2205,057,459108,846Aug 11 05:33 PM
Reedy Thomas W JREVP of FinanceAug 10Sale102.1874,2207,583,80034,626Aug 11 05:33 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryAug 10Sale102.118,863905,00124,440Aug 11 05:33 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryAug 07Option Exercise51.6315,124780,85239,564Aug 11 05:33 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryAug 07Sale100.2615,1241,516,33224,440Aug 11 05:33 PM
Lyski JamesEVP & Chief Marketing OfficerAug 04Option Exercise63.0673,2354,618,34581,678Aug 05 04:17 PM
Lyski JamesEVP & Chief Marketing OfficerAug 04Sale99.4073,2357,279,5598,443Aug 05 04:17 PM
Daniels Jon GSVP, CAFJul 23Option Exercise73.7621,7171,601,84623,197Jul 27 04:20 PM
Daniels Jon GSVP, CAFJul 23Sale99.2521,7172,155,4421,480Jul 27 04:20 PM
FOLLIARD THOMAS JDirectorJul 22Option Exercise73.76254,73118,788,959466,687Jul 23 04:38 PM
Cafritz Diane LSVP & CHROJul 22Option Exercise51.633,000154,89011,208Jul 23 04:38 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJul 22Option Exercise73.7633,0262,435,99857,466Jul 23 04:38 PM
Livesay Jill AVP, Controller & PAOJul 22Sale98.002,107206,4864,933Jul 23 04:38 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJul 22Sale97.8933,0263,232,91524,440Jul 23 04:38 PM
FOLLIARD THOMAS JDirectorJul 22Sale97.61254,73124,863,310211,956Jul 23 04:38 PM
Cafritz Diane LSVP & CHROJul 22Sale97.096,562637,1054,646Jul 23 04:38 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJul 21Option Exercise73.765,781426,40730,221Jul 23 04:38 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJul 21Sale96.125,781555,67024,440Jul 23 04:38 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJul 17Option Exercise73.7612,525923,84436,965Jul 20 04:56 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJul 17Sale95.7612,5251,199,39424,440Jul 20 04:56 PM
Hill Edwin JEVP & COOJul 16Option Exercise63.5597,5326,198,110109,568Jul 20 04:56 PM
Hill Edwin JEVP & COOJul 16Sale95.04101,3109,628,2998,258Jul 20 04:56 PM
Daniels Jon GSVP, CAFJul 15Option Exercise73.7621,7171,601,84627,448Jul 17 04:16 PM
Daniels Jon GSVP, CAFJul 15Sale94.0225,9682,441,5111,480Jul 17 04:16 PM
BLAYLOCK RONALD EDirectorJul 13Sale89.3710,200911,57417,046Jul 15 06:12 PM
Mayor-Mora Enrique NSVP & CFOJun 23Option Exercise61.9741,1002,546,95542,886Jun 25 05:05 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJun 23Option Exercise73.761,20088,51225,640Jun 25 05:04 PM
Wilson Charles JosephSVPJun 23Option Exercise63.6539,0852,487,70745,603Jun 25 05:06 PM
Shamim MohammadSVP and CIOJun 23Option Exercise51.6315,782814,82524,337Jun 25 05:05 PM
Reedy Thomas W JREVP of FinanceJun 23Option Exercise54.7948,2672,644,52888,323Jun 25 08:32 PM
Reedy Thomas W JREVP of FinanceJun 23Sale92.5053,6974,966,74634,626Jun 25 08:32 PM
Shamim MohammadSVP and CIOJun 23Sale91.8715,7821,449,8478,555Jun 25 05:05 PM
Wilson Charles JosephSVPJun 23Sale92.4639,0853,613,7866,518Jun 25 05:06 PM
MARGOLIN ERIC MEVP, Gen. Counsel & SecretaryJun 23Sale94.321,200113,18424,440Jun 25 05:04 PM
Mayor-Mora Enrique NSVP & CFOJun 23Sale92.1537,5003,455,5465,386Jun 25 05:05 PM
Goodman ShiraDirectorApr 17Buy63.911,55099,06126,439Apr 21 04:17 PM